We are live on ! Find out more

1,745 hedge funds and large institutions have $107B invested in Merck in 2016 Q1 according to their latest regulatory filings, with 98 funds opening new positions, 754 increasing their positions, 675 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 83

12% more repeat investments, than reductions

Existing positions increased: 754 | Existing positions reduced: 675

1.44% more ownership

Funds ownership: 77.23%78.67% (+1.4%)

1% more funds holding in top 10

Funds holding in top 10: 105106 (+1)

1% less funds holding

Funds holding: 1,7551,745 (-10)

5% less capital invested

Capital invested by funds: $112B → $107B (-$5.17B)

10% less call options, than puts

Call options by funds: $693M | Put options by funds: $769M

Holders
1,745
Holders Change
-10
Holders Change %
-0.57%
% of All Funds
46.48%
Holding in Top 10
106
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+0.95%
% of All Funds
2.82%
New
98
Increased
754
Reduced
675
Closed
83
Calls
$693M
Puts
$769M
Net Calls
-$76.2M
Net Calls Change
-$112M
Name Holding Trade Value Shares
Change
Change in
Stake
JWBC
1376
J.W. Burns & Co
New York
$486K -$26.7K -545 -5%
EIM
1377
Emerson Investment Management
Massachusetts
$484K -$23.8K -486 -5%
LGC
1378
Laurel Grove Capital
California
$483K -$20.5K -419 -4%
AI
1379
Accredited Investors
Minnesota
$483K +$1.18K +24 +0.3%
T
1380
Thomaspartners
Massachusetts
$477K +$1.32K +27 +0.3%
RHJA
1381
Rice Hall James & Associates
California
$476K
PAM
1382
PT Asset Management
Illinois
$476K +$41.8K +854 +10%
HCC
1383
Hirtle Callaghan & Co
Pennsylvania
$474K +$430K +8,788 +1,436%
WOC
1384
West Oak Capital
California
$474K +$30.8K +629 +7%
NP
1385
NS Partners
United Kingdom
$472K +$458K +9,353 New
WP
1386
WMS Partners
Maryland
$471K -$147 -3 -0%
PFS
1387
Physicians Financial Services
North Carolina
$471K
BSB
1388
Bangor Savings Bank
Maine
$471K +$4.7K +96 +1%
HI
1389
Hendershot Investments
Virginia
$464K -$6.91K -141 -2%
ICM
1390
IronBridge Capital Management
Illinois
$463K -$580K -11,843 -56%
MA
1391
MCF Advisors
Kentucky
$463K -$50.4K -1,029 -10%
HFBOT
1392
Home Federal Bank of Tennessee
Tennessee
$460K
GI
1393
Glovista Investments
New Jersey
$458K -$10.3K -210 -2%
PGIM
1394
Pacific Global Investment Management
California
$455K -$14.5K -297 -3%
GC
1395
Grimes & Company
Massachusetts
$453K -$28.4K -580 -6%
BOIA
1396
Bush ODonnell Investment Advisors
Missouri
$453K
PCA
1397
Private Capital Advisors
Connecticut
$450K
MKC
1398
M. Kraus & Co
Vermont
$449K -$2.6K -53 -0.6%
SFM
1399
Signature Financial Management
Virginia
$439K +$8.62K +176 +2%
NPIT
1400
National Penn Investors Trust
Pennsylvania
$435K -$335K -6,841 -44%

MRK Hedge Fund Activity: Q1 2016 in Review

1,745 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2016, worth a combined $107B — down 4.6% from $112B a quarter earlier.

Buyers outnumbered sellers: 98 funds opened new MRK positions and 83 closed out — a net gain of 15 holders — while 754 added to existing stakes and 675 trimmed.

The largest buyer was Royal London Asset Management, adding an estimated $1.82B. The largest seller was Janus Henderson Investors US, cutting an estimated $193M.

  • 1,745 institutional investors held Merck (MRK) as of Q1 2016, down from 1,755 in Q4 2015.
  • Funds reported $107B of Merck stock for Q1 2016, down 4.6% quarter-over-quarter.
  • 98 funds opened new Merck positions in Q1 2016 and 83 closed out, a net change of +15 holders.
  • The largest Merck buyer in Q1 2016 was Royal London Asset Management, an estimated $1.82B added.
  • The largest Merck seller in Q1 2016 was Janus Henderson Investors US, an estimated $193M sold.

Based on aggregated 13F filings for Q1 2016.